AI
ENVB icon

AdvisorShares Investments’s Enveric Biosciences ENVB Stock Holding History

AdvisorShares Investments’s Portfolio ENVB Stock Details ENVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.9K Buy
35,417
+18,443
+109% +$44.3K 0.01% 263
2026
Q1 		$32.9K Hold
16,974
– – 0.01% 273
2025
Q4 		$61.6K Buy
16,974
+1
+0% +$7 0.01% 283
2025
Q3 		$130K Buy
16,973
+8,333
+96% +$109K 0.02% 252
2025
Q2 		$125K Buy
8,640
+1,113
+15% +$16.9K 0.02% 237
2025
Q1 		$118K Buy
7,527
+4,194
+126% +$145K 0.02% 240
2024
Q4 		$215K Buy
3,333
+1,294
+63% +$93.9K 0.04% 221
2024
Q3 		$174K Buy
2,039
+278
+16% +$25.6K 0.03% 222
2024
Q2 		$190K Buy
1,761
+434
+33% +$65.4K 0.03% 225
2024
Q1 		$239K Buy
1,327
+539
+68% +$104K 0.04% 219
2023
Q4 		$184K Sell
788
-28
-3% -$8.6K 0.04% 231
2023
Q3 		$339K Buy
816
+258
+46% +$116K 0.09% 166
2023
Q2 		$338K Sell
558
-237
-30% -$115K 0.1% 162
2023
Q1 		$240K Buy
795
+149
+23% +$62.7K 0.08% 178
2022
Q4 		$238K Buy
646
+211
+49% +$117K 0.07% 207
2022
Q3 		$331K Buy
435
+296
+213% +$373K 0.09% 206
2022
Q2 		$268K Buy
139
+37
+36% +$78.7K 0.07% 126
2022
Q1 		$304K Buy
102
+69
+209% +$305K 0.05% 131
2021
Q4 		$279K Buy
33
+29
+725% +$408K 0.03% 134
2021
Q3 		$74K Buy
+4
New +$77.7K 0.01% 183

Other funds holding ENVB

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $20.5B AUM 24.45% 1-Year Est. Return

AdvisorShares Investments's ENVB Position: Q2 2026 in Review

AdvisorShares Investments increased its Enveric Biosciences (ENVB) stake by 109% in Q2 2026, buying an estimated $44.3K and bringing the position to 35,417 shares worth $48.9K. The position accounts for 0.01% of the portfolio, ranked #263.

AdvisorShares Investments first reported a position in ENVB in Q3 2021 and has held it in 20 quarters since. The position peaked at $339K in Q3 2023. 15 funds tracked by Wall St. Rank hold ENVB as of Q2 2026.

  • AdvisorShares Investments held 35,417 shares of Enveric Biosciences worth $48.9K as of Q2 2026.
  • AdvisorShares Investments bought 18,443 Enveric Biosciences shares in Q2 2026, an estimated $44.3K.
  • Enveric Biosciences made up 0.01% of AdvisorShares Investments's portfolio in Q2 2026, its #263 holding.
  • AdvisorShares Investments first reported a position in Enveric Biosciences in Q3 2021 and has held it in 20 quarters since.
  • AdvisorShares Investments's Enveric Biosciences position peaked at $339K in Q3 2023.
  • 15 funds tracked by Wall St. Rank held Enveric Biosciences as of Q2 2026.

Based on AdvisorShares Investments's 13F filing for Q2 2026, filed 11 Aug 2026.